Related Experiment Video
Updated: Jun 6, 2025
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Congenital Infantile Fibrosarcoma - A Potentially Fatal Condition
Bipin Arun Ghanghurde1, Kushal Shah1, Minnie Bodhanwala1
1Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India.
Insights
Congenital infantile fibrosarcoma (CIF) is a rare infant tumor. Early diagnosis and treatment, including amputation in severe cases like DIC, are vital for limb and life preservation.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Dermatopathology
Background:
- Congenital infantile fibrosarcoma (CIF) is a rare malignant tumor in infants.
- CIF can be misdiagnosed as vascular malformations or hemangiomas.
- Timely diagnosis and intervention are critical for patient outcomes.
Observation:
- A 4-month-old infant presented with CIF of the left forearm and arm.
- The tumor manifested as a swelling with a bleeding ulcer.
- The infant developed disseminated intravascular coagulation (DIC) during hospitalization.
Findings:
- The case highlights the aggressive nature of CIF.
- Disseminated intravascular coagulation (DIC) is a severe complication of CIF.
- Prompt surgical intervention, including amputation, may be life-saving.
Implications:
- This case underscores the importance of considering CIF in infant limb swellings.
- Aggressive management, including amputation, may be necessary for CIF with complications.
- Further research into CIF diagnosis and treatment is warranted.
Abstract:
Congenital infantile fibrosarcoma (CIF) is a rare prenatal malignant tumour that occurs in infants and can be difficult to distinguish from vascular malformation or haemangiomas. Early diagnosis and treatment are crucial for saving both limb and life. We report a 4-month-old infant with CIF of the left forearm and arm which presented with a bleeding ulcer over the swelling. During admission, the child developed disseminated intravascular coagulation (DIC) necessitating a life-saving above-elbow amputation. Level of Evidence: Level V (Therapeutic).
More Related Videos
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Related Concept Videos
01:20Inborn Errors of Metabolism
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
01:07Teratogenicity